This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. MRNA slipped 1.57% to $161.51 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to 12,368.98 and Dow Jones Industrial Average DJIA falling 0.14% to 32,798.40. The stock's fall snapped a two-day winning streak. Moderna Inc. closed $335.98 below its 52-week high ($497.49), which the company reached on August 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. ABBV fell 2.29% to $140.22, Amgen Inc. AMGN fell 0.74% to $245.64, and AstraZeneca PLC ADR AZN fell 0.88% to $65.65. Trading volume (3.8 M) remained 1.4 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 1, 2022.
(END) Dow Jones Newswires
August 01, 2022 16:31 ET (20:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.